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Abstract 
Review on BOK, with data on DNA, on the protein 




Other names: Mtd, BOKL, BCL2-like 9, BCL2L9, 
MGC4631 
Local order 
MIR3133, STK25, BOK, THAP4, ATG4B 




The BCL2 ovarian killer gene (BOK) is located on 
the chromosome 2q and comprises 6 exons and 5 
intervening introns.  
The number of the verified transcripts is nine and 
eight of them have recently been discovered and 
submitted to GenBank (NM_032515.4, 
MK354020.1, MK354019.1, MK354018.1, 
MK354017.1, MK328047.1, MK328046.1, 
MK328045.1, MK328044.1).  
So far, 2 alternative, untranslated first exons, 5 
alternative second exons with a length of 249, 119, 
138, 100, and 97 nucleotides (nt) respectively, and 3 
distinct fifth exons with a length of 164, 50 and 19 nt 
have been identified.  
Regarding the two possible first exons, the first is 
249-nt long and the second one has a length of 171 
nt.  
However, the length of the second possible exon is 
calculated based on in silico analysis. The 5' 
untranslated region (UTR) has not been extensively 
studied, and therefore an uncertainty exists regarding 
the 5' end. The exon 3 consists of 193 nt, the exon 4 
of 129 nt, and the exon 5 of 164 nt. The exon 3 is an 
outcome of computational analysis of expressed 
sequence tags (ESTs) and has not been validated yet. 
Furthermore, there is evidence of an extension in the 
second exon and a truncated version of the sixth exon 
lacking an internal segment in human, based on our 
preliminary results and their existence in other 
primates, such as in chimpanzee. 
Transcription 
The aforementioned transcript NM_032515.4 is 
considered as mRNA and encodes the protein 
isoform NP_115904.1. In silico analysis revealed 
that 3 (MK328044.1, MK328045.1, MK328047.1) 
out of the 9 transcripts have an open reading frame 
and could hence be translated to a functional protein 
isoform.  
Moreover, there is a predicted transcript, derived 
from computational analysis, with indications of 
being a coding mRNA. The presence of three 
different stop codons is well-worth to be mentioned. 
The rest of the transcripts do not seem to have an 
open reading frame and, therefore, are considered as 
candidates for non-sense mediated mRNA decay.  
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Figure 1. Schematic illustration of BOK transcripts structure with their accession number. The boxes illustrate the exons, the 
lines illustrate the introns, while the numbers inside the boxes and above the lines represent the length of the exons and the 
introns, respectively. The presence of the two parallel lines (//) indicates that these shapes are not constructed based on a scale. 
The grey-colored regions of the boxes represent the coding regions of the mRNA, while the uncolored ones depict the non-
coding regions. The question marks (?) symbolize an undetermined untranslated region (UTR), while the arrows and the 
asterisks indicate the position of the translation start (ATG) codon and the translation stop (TGA) codon, respectively. 
 
Extensive expression sequence tag (EST) analysis 
led to the discovery of many more transcripts, 
resulting from alternative splicing. 
The alternative splicing of BOK pre-mRNA 
producing several distinct transcripts is expected to 
result in protein isoforms with a different pattern of 
BCL2 homology (BH) domains or to transcripts with 
regulatory function. For instance, the presence of a 
potential transcript, derived from EST analysis, 
lacking exons 2, 3, and 4 is an example of a possible 
alternative BH motif.  
These results underline the need of further research 
in the field of alternative splicing in BOK, as it will 
shed light on the enigmatic cellular role of BOK. 
Regarding its expression levels, high RNA levels 
have been observed in fat, liver, lung, kidney and 
prostate tissue. However, its expression in particular 
cancerous tissues, as it defined by distinct research 
studies, seems to be downregulated. 
Pseudogene 
None. Even though pseudogenes are absent, an 
antisense gene has been characterized, known as 
BOKAS. Both genes are located in the same region, 
but in different orientations. There is a restricted 
overlap between these two genes in the region of the 
first exon of BOK. The BOKAS comprises two 
exons and is considered as a non-coding RNA with 
possible regulating properties as far as the BOK-
induced apoptosis is concerned. Its presence has only 
been validated in testis and in particular cancer 
tissues, but not in the majority of normal ones 
(Zhang et al., 2009). 
Protein 
Description 
The BOK gene encodes a main protein isoform of 
the BCL2 family, named BOK-L, with a length of 
212 amino acid residues and a mass of 23.3 kDa. It 
is characterized by the presence of the BH1, BH2, 
BH3, and BH4 domains, a C-terminal 
transmembrane domain, and a nuclear export signal. 
The existence of the BH4 domain is considered as 
typical feature for BCL2 family proteins with anti-
apoptotic function. Therefore, this finding creates an 
ambiguity regarding the cellular role of this 
molecule (Soleymanlou et al., 2005).  
Except of the full-length protein, an additional 
isoform has been detected with a truncated BH3 
domain (170 aa) in mouse, named Bok-S. It is 
hypothesized that this isoform derives from the 
deletion of 43 aa residues from the main isoform and 
leads to a fusion of the N-terminal-half of its BH3 
domain to the C-terminal half of the BH1 domain.  
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Figure 2. Schematic illustration of the two curated amino acid sequences of BOK protein isoforms in Homo sapiens, 
accompanied by the location of their BH domains. 
 
An alternative splice isoform has been discovered in 
human tissues (BOK-P, also known as Mtd-P) with 
a length of 135 aa residues. 
This isoform is considered to result from the deletion 
of exon 2 and part of the 5' UTR (249 bp deletion). 
Due to the 249-bp deletion, this isoform comprises 
only BH1 and BH2 domains, and perhaps a partial 
BH3 domain (Soleymanlou et al., 2005). Because of 
the absence of BH4 domain in this isoform, the pro-
apoptotic function of BOK could be attributed to this 
particular molecule. 
Expression 
It was initially discovered in ovarian tissue, hence 
the designation "ovarian killer". After further 
research, it has been detected in other tissue types as 
well, including brain, liver, rectum, kidney, but its 
main expression has been observed in reproductive 
tissues (Jaaskelainen et al., 2010,Echeverry et al., 
2013,Llambi et al., 2016). 
Localisation 
BOK is localized in multiple intracellular 
membranes, including ER, Golgi, and associated 
membranes (Echeverry et al., 2013). A fraction of 
BOK has also been detected in outer mitochondrial 
membrane or in contact sites between the 
mitochondria and the endoplasmic reticulum (ER) 
(Llambi et al., 2016). The BOK-P isoform has also 
been detected in the cytoplasm (Ray et al., 2010). 
Function 
Due to the homology of BOK with BAX and BAK1, 
its pro-apoptotic properties were proposed. Contrary 
to BAK and BAX proteins, BOK is not well-studied 
and its role remains enigmatic, probably because of 
its low expression in the cell lines which are 
commonly used for experiments. At the beginning, 
BOK was considered to act similarly to BAX and 
BAK because of the formation of clustered 
structures in the outer mitochondrial membrane. 
These structures indicate a possible association with 
cytochrome c release. However, the results of a 
recent valid research study demonstrate the ability of 
BOK to induce cytochrome c release, and 
subsequent apoptosis in BAK/BAX deficient cell 
model systems. Therefore, the ability of BOK to 
induce apoptosis in a BAK- and BAX- independent 
way is proposed (Einsele-Scholz et al., 2016). 
Moreover, BOK seems to play a role in multiple 
signaling pathways, some of which are mentioned 
below; it is involved in granulose cell apoptosis 
through Caspase-3 ( CASP3) activation 
(Jaaskelainen et al., 2010) and in the intrinsic 
apoptotic mechanism depending on the tumor 
protein p53 ( TP53) (Yakovlev et al., 2004). This 
mechanism is activated in response to DNA damage. 
It is, also, capable of inducing apoptosis without the 
prerequisite of heterodimerization with other pro-
apoptotic members of BCL2 family, when the ER-
associated protein degradation (ERAD) system is 
inhibited. More specifically, BOK, independently of 
BAX and BAK, participates in mitochondrial outer 
membrane permeabilization, leading to cytochrome 
c release (Einsele-Scholz et al., 2016). In the early 
stages of placental development, regulation of 
trophoblast cell proliferation could be achieved by 
BOK through its effect on the G1/S transition. This 
can be achieved by the regulation of cyclin E1 
(CCNE1) expression (Ray et al., 2010). Finally, 
there are indications that BOK can disturb MCL1 
and Beclin-1 (BECN1) interaction and therefore has 
an effect on the induction of autophagy (Kalkat et al., 
2013).  
BOK protein has been examined more thoroughly in 
the mouse. The results of these studies revealed 
alternative functions of this molecule. In 
circumstances of ER stress, BOK induces positive 
regulation of EIF2AK3 (PKR-like ER kinase, 
PERK) to initiate a downstream unfolded protein 
response and a downstream regulation of BAX/BAK 
activation, thus leading to the mitochondrial 
apoptotic pathway (Carpio et al., 2015). Besides its 
pro-apoptotic role, there are indications that BOK 
has anti-apoptotic properties during neuronal 






Atlas Genet Cytogenet Oncol Haematol. 2019; 23(10) 302 
 
apoptotic process. In the aforementioned process, it 
regulates neuronal calcium homeostasis and 
mitochondrial bioenergetics, resulting to 
downregulation of poly ADP-ribose polymerase 
(PARP1)-dependent cell death. This mechanism is 
considered as a response to N-methyl-D-aspartate 
excitation (D'Orsi et al., 2016). Finally, Bok seems 
to strongly interact with inositol 1,4,5-trisphosphate 
(IP3) receptors via the BH4 domain. Regarding the 
outcome of a research study, this interaction, 
possibly, enhances the structural stability of both IP3 
receptor tetramers and Bok, and leads to the 
limitation of overexpressed pro-apoptotic activity of 
BOK. One of the most interesting findings of this 
study was the protection from degradation, which is 
provided to BOK by this interaction. Based on the 
similarity between the human and mouse protein 
isoforms, we could hypothesize that human BOK 
protein could be involved in the aforementioned 
pathways and act in a similar manner. 
Homology 
BOK shares high amino acid sequence homology 
with the pro-apoptotic BCL2 family proteins BAK 
and BAX (Hsu et al., 1997). 
Mutations 
Germinal 
To the best of our knowledge, no germinal mutation 
has been discovered in vivo. 
Somatic 
To the best of our knowledge, none somatic mutation 
has been discovered in vivo. However, an in-vitro 
mutation in positions 71-73 in leucine-rich region 
led to significant accumulation of BOK in the 
nucleus and to increased apoptotic activity. It is 
significant to mention that BOK is the only BCL2 
family member possessing this leucine-rich region 




There are indications that BOK could act as a 
possible prognostic biomarker in colorectal cancer 
(CRC), because of the association of its high 
expression levels with poor disease-free and overall 
survival in CRC patients. However, in the 
aforementioned research study, decreased 
expression levels of BOK protein were measured in 
stage II and III CRC tumors compared to paired non-
cancerous tissue specimens. These seemingly 
contradictory results highlight the differential 
function of BOK and its involvement in multiple 
activities. This assumption regarding the different 
activities of BOK in CRC is additionally supported 
by its various associations with distinct protein 
molecules. More specifically, a strong association 
was revealed between BOK and CALR 
(Calreticulin), but no significant correlation was 
observed between BOK and other ER-stress 
markers, including cleaved CASP3 (Carberry et al., 
2018). 
Non-small cell lung carcinoma 
Prognosis 
Overexpression of BOK in lung adenocarcinoma-
derived A549 cells resulted in inhibition of TGFβ-
induced migration and epithelial-to-mesenchymal 
transition of these cells. Furthermore, after the 
comparison of BOK levels among patients with non-
small cell lung carcinoma (NSCLC), tumors of grade 
2 and 3 and/ or with nodal metastasis had lower BOK 
expression levels than tumors of grade 1 without 
nodal metastasis. These results support the favorable 
prognostic value of BOK in NSCLC patients. More 
specifically, there are indications that the BOK 
overexpression in NSCLC patients is associated with 
longer overall survival (Moravcikova et al., 2017). 
Preeclampsia 
Preeclampsia is a disorder that affects 5-8% of 
pregnancies worldwide, with frequent fatal 
consequences for the mother and the fetus, as well. 
Preeclampsia has been attributed to extensive 
trophoblast cell death, which seems to be related 
with the presence of a group of bioactive 
sphingolipids, named ceramides.  
The aggregation of these structures affects BOK by 
increasing its expression levels, resulting to 
extensive trophoblast autophagy and death. It is 
important to clarify that preeclampsia is also 
correlated with increased phosphorylation of 
dynamin 1-like protein (DNM1L, also known as 
DRP1).  
Based on the results of a recent research study, a 
direct effect of BOK on DNM1L expression is 
highlighted on DNM1L expression, and hence its 
pivotal role in mitochondrial energetics. These 
results enhance further the importance of BOK in 
this disease and underscore its potential drug 
targeting for possible disease cure (Ausman et al., 
2018). 
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